-
Mashup Score: 2
KXL Radio Portland, Oregon asked Cardiologist Dr. Fahmi Farah to come on the air for an interview on 3/25/24 with host Tim Lantz. Contact Dr. Farah:https://b…
Source: www.youtube.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 5The next act for a biotech rainmaker - 2 month(s) ago
Novo Nordisk can barely make enough of Wegovy to satisfy demand for the dramatically effective obesity treatment. But scientists in the company’s research ranks are already at work on a moonshot treatment that would render that weekly injection obsolete.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 25
Novo Nordisk’s ideas about long-lasting molecules are a long way off from materializing into actual drugs, but it’s a window into its thinking as the obesity field grows more competitive.
Source: www.statnews.comCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 11As supply crunch starts to ease, Novo Nordisk to offer more doses of obesity drug Wegovy to U.S. patients - 3 month(s) ago
Novo Nordisk has increased the U.S. availability of obesity drug Wegovy, after massive demand and a supply crunch led it to limit such doses.
Source: www.statnews.comCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 5Wegovy may have another helpful trick: fighting inflammation via the brain, study finds - 4 month(s) ago
“This is a new model for the anti-inflammatory actions of GLP-1” drugs and has implications for how Wegovy and others are prescribed, a researcher says.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 5Wegovy may have another helpful trick: fighting inflammation via the brain, study finds - 4 month(s) ago
“This is a new model for the anti-inflammatory actions of GLP-1” drugs and has implications for how Wegovy and others are prescribed, a researcher says.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Pharmalittle: Novo halts Ozempic kidney failure trial after early signs of success; GSK settles California Zantac lawsuit - 6 month(s) ago
Novo Nordisk plans to stop a trial of Ozempic to treat kidney failure after an interim analysis showed the drug would succeed.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Judge dismisses Novo Nordisk lawsuit over compounded versions of Ozempic and Wegovy - 6 month(s) ago
In a setback for Novo Nordisk, a U.S. judge dismissed its lawsuit accusing a compound pharmacy of selling versions of its Wegovy and Ozempic medicines,
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0The Wegovy Shortage Drags On, Leaving Patients in Limbo - 6 month(s) ago
The situation has left many patients frustrated and unable to start taking the weight loss drug.
Source: www.nytimes.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Pharmalittle: Novo faces patent challenge on Wegovy and Ozempic; Senate panel moves to address drug shortages - 7 month(s) ago
A U.S. Patent Office tribunal agreed to review the validity of a Novo Nordisk patent related to its blockbuster drugs Ozempic and Wegovy.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
Medicare to cover #Wegovy for heart disease risk reduction - KXL Radio Portland, Oregon recently asked me to come on the air to give my thoughts on this... https://t.co/5LvJLvgqzK